GLP1R and chronic kidney disease: For individuals with advanced chronic kidney disease (CKD), particularly those not undergoing hemodialysis, guidelines such as KDIGO prioritize the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs).